We observed restoration of synaptophysin and PSD‐95 immunoreactivity in the AD brain after treatment with either hNSC‐ or iMGL‐derived EVs, indicating a comparable neuroprotective effect in vivo. This evidence concerns the gene SYP and Alzheimer disease.